Repligen (NASDAQ: RGEN) reported Q2 EPS of $0.53, $0.05 better than the analyst estimate of $0.48. Revenue for the quarter came in at $159.2 million versus the consensus estimate of $165.93 million.

GUIDANCE:

Repligen sees FY2023 revenue of $635-665 million.

For earnings history and earnings-related data on Repligen (RGEN) click here.